Trials / Sponsors / Vital Therapies, Inc.

Vital Therapies, Inc.

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjec Acute Alcoholic Hepatitis	Phase 3	2016-01-01
Terminated	Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF) Acute Liver Failure, Fulminant Hepatic Failure, Primary Graft Non-Function	Phase 2	2014-10-01
Terminated	To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failu Severe Acute Alcoholic Hepatitis	Phase 3	2014-04-01
Completed	Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Acute Alcoholic Hepatitis	Phase 3	2013-02-01
Withdrawn	Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion Acute Liver Failure	Phase 2 / Phase 3	2010-06-01
Completed	Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis Acute On Chronic Hepatitis	Phase 2 / Phase 3	2009-09-01
Withdrawn	Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failu Fulminant Hepatic Failure	Phase 2	2009-03-01
Completed	Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficien Acute Hepatitis, Chronic Hepatitis	Phase 1 / Phase 2	2008-10-01
Completed	Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure Fulminant Hepatic Failure	Phase 2	2002-01-01
No Longer Available	Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery Liver Failure	—	—